Percentiles of intrauterine placental volume and placental volume relative to fetal volume: A prospective magnetic resonance imaging study.


Journal

Placenta
ISSN: 1532-3102
Titre abrégé: Placenta
Pays: Netherlands
ID NLM: 8006349

Informations de publication

Date de publication:
04 2022
Historique:
received: 10 11 2021
revised: 07 02 2022
accepted: 25 02 2022
pubmed: 9 3 2022
medline: 15 4 2022
entrez: 8 3 2022
Statut: ppublish

Résumé

We aimed to provide percentiles of intrauterine placental growth and placental growth relative to fetal growth (placental to fetal ratio) by measuring placental and fetal volumes by magnetic resonance imaging (MRI). In this prospective study, 107 unselected singleton pregnancies were examined by MRI at gestational week 27 and 37. Based on the estimated volumes of the placenta and the fetus, we calculated median and percentiles at gestational weeks 27 and 37. Median placental volume at gestational week 27 was 513 cm At gestational week 27, the placental volume was about half the size of the fetal volume, whereas at week 37, the placental volume was about one third of the fetal volume. This finding suggests that placental growth was less prominent than fetal growth after gestational week 27. Knowledge about the distribution of intrauterine placental size in the general population of pregnancies are prerequisites for diagnosing abnormal placental size.

Identifiants

pubmed: 35259595
pii: S0143-4004(22)00068-6
doi: 10.1016/j.placenta.2022.02.023
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

40-45

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

H F Peterson (HF)

Department of Obstetrics and Gynecology, Akershus University Hospital, P.O. Box 1000, N-1478, Lørenskog, Norway; Institute of Clinical Medicine, University of Oslo, P.O. Box 1171, Blindern, N-0318, Oslo, Norway. Electronic address: Helene.Fjeldvik.Peterson@ahus.no.

A Eskild (A)

Department of Obstetrics and Gynecology, Akershus University Hospital, P.O. Box 1000, N-1478, Lørenskog, Norway; Institute of Clinical Medicine, University of Oslo, P.O. Box 1171, Blindern, N-0318, Oslo, Norway.

S Sommerfelt (S)

Department of Obstetrics and Gynecology, Akershus University Hospital, P.O. Box 1000, N-1478, Lørenskog, Norway.

K Gjesdal (K)

Department of Diagnostic Imaging, Akershus University Hospital, P.O. Box 1000, N-1478, Lørenskog, Norway.

A S Borthne (AS)

Institute of Clinical Medicine, University of Oslo, P.O. Box 1171, Blindern, N-0318, Oslo, Norway; Department of Diagnostic Imaging, Akershus University Hospital, P.O. Box 1000, N-1478, Lørenskog, Norway.

L Mørkrid (L)

Institute of Clinical Medicine, University of Oslo, P.O. Box 1171, Blindern, N-0318, Oslo, Norway; Department of Medical Biochemistry, Oslo University Hospital, P.O. Box 4950 Nydalen, N-0424, Oslo, Norway.

V Hillestad (V)

Department of Obstetrics and Gynecology, Akershus University Hospital, P.O. Box 1000, N-1478, Lørenskog, Norway; Institute of Clinical Medicine, University of Oslo, P.O. Box 1171, Blindern, N-0318, Oslo, Norway; Department of Diagnostic Imaging, Akershus University Hospital, P.O. Box 1000, N-1478, Lørenskog, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH